jeudi 13 juin 2019

Onco Actu du 13 juin 2019


1. BIOLOGIE



Multi-omics Study of Gut Microbiota in Colorectal Cancer [ESMO]











Transmissible cancer and the evolution of sex [PLOS Biology]











1.1 BIOLOGIE - GÉNOME



Not silent at all [DKFZ]










1.4 BIOLOGIE - TECHNOS



New gene-editing system precisely inserts large DNA sequences into cellular DNA [MIT]











2.11 ETIOLOGIE - ALIMENTATION



Changing your meat-eating habits could mean a longer life, study suggests [CNN]











Swapping one portion of red meat a day for fish or nuts could cut risk of early death by almost a fifth [The Telegraph]











4.13 DÉP., DIAG. & PRONO. - PEAU



Laser detects tumor cells in bloodstream, potentially improving melanoma screening and treatment [Science]










4.15 DÉP., DIAG. & PRONO. - IMAGERIE



Whole-body PET scanner produces 3D images in seconds [Nature]










5. TRAITEMENTS



Drug to Replace Chemotherapy May Reshape Cancer Care [Bloomberg]











Radiation plus chemotherapy doesn’t improve endometrial cancer recurrence-free survival [Northwestern University]










5.2.1 PHARMA - PARTENARIATS



Intermountain Increases Investment in Precision Health Through Decode Genetics Sequencing Study [Genome Web]











Intermountain Healthcare and deCODE genetics Launch Groundbreaking DNA Study of 500,000 People to Find New Links Between Genetics and Disease [Amgen]











5.2.2 PHARMA - FUSIONS & ACQUISITIONS



Sobi to buy Novimmune R&D assets, lay off 90 staff [Fierce Biotech]











5.2.3 PHARMA - ÉCONOMIE



ADC Therapeutics bumps up series E by $76M, prepares lead drug for 2020 filing [Fierce Biotech]











Prelude Therapeutics nabs $60M series B, gains biopharma veteran as CMO [Fierce Biotech]











ADC Therapeutics Announces Completion of a Series E Financing Expansion [ADC Therapeutics]











ADC Therapeutics beefs up monster $200M round with fresh $76M haul [EndPoints]











OrbiMed-backed Prelude Therapeutics raises $60M to tackle resistance to cancer treatments [EndPoints]











5.4 TRAITEMENTS - ECONOMIE



Kidney and lung cancer drugs approved on the NHS in Scotland [Cancer Research UK]











5.6 ESMO



Antibodies Against HPV16 Can Develop up to 40 Years Before Throat Cancer is Diagnosed and Mark a 100-fold Increase in Risk in White People [Annals of Oncology Press Release]











5.9.3 EHA



Seattle Genetics Announces Multiple ADCETRIS® (Brentuximab Vedotin) Presentations at the Congress of the European Hematology Association (EHA) and the International Conference on Malignant Lymphoma (ICML) [Seattle Genetics]











GSK announces data on anti-BCMA antibody-drug conjugate in patients with relapsed/refractory multiple myeloma to be presented at European Hematology Association (EHA) Congress [GSK]











6.1 OBSERVATION



Cancer survival rates in the young show inconsistent progress [EurekAlert!]











6.10.1 POLITIQUES (USA)



Biden says as president he wants to 'cure cancer' [The Hill]











6.11 PATIENTS



Gabriele Grunewald, Runner Who Chronicled Journey With Cancer, Dies at 32 [NY Times]











6.3 ASSOCIATIONS/FONDATIONS



MMRF Launches CureCloud™ to Advance Precision Medicine [Multiple Myeloma Research Foundation]











6.4 MÉDICO-ÉCO



Canadian panel calls for universal public drug coverage [Reuters]











6.7 DMP, BIG DATA & APPLIS



The Childhood Cancer Data Initiative: Why Data Sharing Is Essential to Progress [NCI]










6.7.2 APPLIS



Dassault Systèmes and Medidata Solutions To Join Forces To Accelerate the Life Sciences Industry Innovation for Patient-Centric Experience Through End-to-End Collaborative Platform [Dassault Systèmes]